Pharmaniaga Berhad
Malaysia’s Largest Integrated Pharmaceutical & Healthcare Group
Pharmaniaga delivers full-spectrum pharmaceutical services: manufacturing, R&D, distribution & medical supplies across Malaysia & beyond.
Opportunities
What we’re looking for?
Biopharmaceuticals
Estimated Budget
Project‑based Negotiation
Partnership Types
OEM / ODM
CDMO / CMO
Technology Licensing
Market Region
Asia Pacific
Company Overview
Pharmaniaga Berhad
Selangor, Malaysia
Malaysia’s largest listed integrated healthcare company, offering research and development, manufacturing, logistics, and distribution of pharmaceuticals and medical supplies. Pharmaniaga is capable of producing products in various forms; from oral solids, liquids and creams to small volume injectables. Its product portfolio encompasses a diverse segment of therapeutic areas such as cardiovascular, diabetes, anti-infectives, pain management, and respiratory, amongst others.
Established Since
1994
Annual Revenue
$50-100 million
Employees
3,500
Business Attribute
Agent/ Distributor
Manufacturer
Business Nature
Biotech/ Diagnostics/ Pharmaceutical/ Regenerative Medicine/ Preventive Medicine
Company Highlights
1
End-to-End Pharma Capability
Manufacturing generics, biopharma, OTC, vaccines & insulin; backed by six plants in Malaysia
2
Strong Logistics & Distribution Network
Extensive warehousing and distribution, 4 major centers in Malaysia and many branches in Indonesia; serving government and private sectors.
3
Regulatory & Quality Excellence
Plants comply with international GMP, PIC/S, ISO standards. Biopharma and vaccine fill-finish capabilities.
Market Presence
Headquartered in Shah Alam, Malaysia, Pharmaniaga serves both domestic and regional markets through its manufacturing, distribution, and hospital-equipment services in Malaysia.
Brands in Charge for Distribution
Generic pharmaceuticals.
Biopharmaceuticals including vaccines, insulin (fill-finish).
Over-the-counter (OTC) and nutraceutical products.
Biopharmaceuticals including vaccines, insulin (fill-finish).
Over-the-counter (OTC) and nutraceutical products.
Strategic Focus Areas
Scale up biopharmaceutical manufacturing, strengthen vaccine & insulin fill-finish capabilities, expand medical devices & hospital equipment portfolio, and enhance supply chain resilience.
Contact Info
Start the Conversation About Our Next Project
Thanks for your interest!
The 2025 section is now closed, but you can add this company to your wishlist. We’ll notify you the moment bookings open again.